Delivery Order SPE2DR25D2005-SPE2DR26FE8E3
- Not listed
- The Defense Logistics Agency awarded a $3,788.86 delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Exforge 10-160 mg tablets (30-count packaging). This is a firm fixed-price delivery order with a completion date of May 13, 2025, and represents a non-set-aside competitive award. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a $15,095.94 delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Exforge 10-160 mg tablets (30-count units). This competitively awarded, firm fixed-price contract is classified as a delivery order with an ultimate completion date of August 18, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. No set-aside designation was utilized for this procurement. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Exforge 5-320 mg tablets (30-count units) with a ceiling value of $11,807.90. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The order is scheduled for ultimate completion by August 26, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 2, 2025, for the supply of Exforge 10-320 mg tablets (30-count) with a ceiling value of $11,442.50. This firm fixed-price delivery order, without a set-aside designation, represents a competitively awarded contract executed under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.999 billion global pharmaceutical support vehicle running through...
- The Defense Logistics Agency awarded a delivery order valued at $5,762.79 to AmerisourceBergen Drug Corp for the supply of Exforge 10-320 mg tablets (30-count units). This competitively awarded, firm fixed-price delivery order was issued on December 19, 2025, with an ultimate completion date of December 22, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading...
- The Defense Logistics Agency awarded a $22,617.45 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Exforge 10-320 mg tablets (30-count). This is a firm fixed-price, non-set-aside contract with a completion date of December 11, 2025, performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Exforge 10-320 mg tablets (30-count units) with a contract ceiling value of $18,372.83. This is a firm fixed-price delivery order with no set-aside designation, issued under competitive procedures. The contract is a child award under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which carries a $999.99 billion ceiling...
- The Defense Logistics Agency awarded a $2,682.39 delivery order to AmerisourceBergen Drug Corp for Exforge 10-320 mg tablets (30 count) on July 21, 2025, with completion scheduled for July 22, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran...
- The Defense Logistics Agency awarded a delivery order valued at $1,014.88 to AmerisourceBergen Drug Corp for the supply of Exforge HCT 10-160-12.5 mg tablets (30-count package) on December 4, 2025, with an ultimate completion date of December 5, 2025. This firm fixed price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract action executed...
- The Defense Logistics Agency awarded a $6,588.62 delivery order to AmerisourceBergen Drug Corp on June 2, 2025, for the supply of Exforge 10-320 mg tablets (30-count units). This firm fixed price delivery order, with an ultimate completion date of June 3, 2025, represents a competitively awarded, non-set-aside contract with performance at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- SPE2DR25D2005Indefinite Delivery Contract
- SPE2DR25D2005-SPE2DR26FE8E3Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Exforge 5-160 mg tablets (30-count units) with a ceiling value of $1,156.73. This firm fixed-price delivery order, which must be completed by December 8, 2025, carries no set-aside designation and was competitively awarded. The order will be fulfilled from AmerisourceBergen's Conshohocken, Pennsylvania location, where the company maintains its corporate headquarters and primary distribution operations for federal pharmaceutical procurement. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle that runs through December 2026. The parent IDC enables AmerisourceBergen to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs and other federal health systems worldwide. Exforge, a combination antihypertensive medication, represents one of the specialized pharmaceutical products delivered under this strategic contract vehicle, which serves critical medical needs across the Department of Defense Healthcare System and related federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/4/25 |